Johannes Gutenberg-Universität Mainz
- 6131/39-0
Franke, Gabriele Helga; Jagla-Franke, Melanie; Kuech, Dieter et al.
A New Routine for Analyzing Brief Symptom Inventory Profiles in Chronic Pain Patients to Evaluate Psychological ComorbidityFRONTIERS IN PSYCHOLOGY. Bd. 12. 2021
Krienke, Christina; Kolb, Laura; Diken, Elif et al.
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitisSCIENCE. Bd. 371. H. 6525. 2021
Krienke, Christina; Kolb, Laura; Diken, Elif et al.
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitisSCIENCE. Bd. 371. H. 6525. 2021 S. 146-+
Villesen, Ida; Langholm, Lasse; Leeming, Diana et al.
A novel liver-specific fibrosis biomarker, PRO-C18L, can predict response to antifibrotic treatment, with a peroxisome proliferator activated receptor -y agonist, in patients with chronic hepatitis CJOURNAL OF HEPATOLOGY. Bd. 75. 2021 S. S633-S633
Erbe, Christina; Hartmann, Luisa; Schmidtmann, Irene et al.
A novel method quantifying caries following orthodontic treatmentSCIENTIFIC REPORTS. Bd. 11. H. 1. 2021
Nourse, Jamie; Danckwardt, Sven
A novel rationale for targeting FXI: Insights from the hemostatic microRNA targetome for emerging anticoagulant strategiesPHARMACOLOGY & THERAPEUTICS. Bd. 218. 2021
Bertero, Edoardo; Heusch, Gerd; Muenzel, Thomas et al.
A pathophysiological compass to personalize antianginal drug treatmentNATURE REVIEWS CARDIOLOGY. Bd. 18. H. 12. 2021 S. 838-852
Wallis, Stuart; Wolska, Nina; Englert, Hanna et al.
A peptide from the staphylococcal protein Efb binds P-selectin and inhibits the interaction of platelets with leukocytesJOURNAL OF THROMBOSIS AND HAEMOSTASIS. Bd. 20. H. 3. 2021 S. 729-741
Moehler, Markus; Michel, Maurice; Stein, Alexander et al.
A Phase I dose-escalation study of third-line regorafenib with trifluridine/tipiracil in metastatic colorectal cancerFUTURE ONCOLOGY. Bd. 17. H. 25. 2021 S. 3309-3319
Sangro, Bruno; Harding, James J.; Johnson, Matthew et al.
A phase III, double-blind, randomized study of nivolumab (NIVO) and ipilimumab (IPI), nivo monotherapy or placebo plus transarterial chemoembolization (TACE) in patients with intermediate-stage hepatocellular carcinoma (HCC).JOURNAL OF CLINICAL ONCOLOGY. Bd. 39. H. 3. 2021